secwatch.observer — SEC 8-K summary
======================================

Issuer:     RAPID MICRO BIOSYSTEMS, INC. (RPID)
CIK:        0001380106
Form:       8-K
Filed at:   2023-05-05T23:59:59+00:00
Accession:  0001380106-23-000072
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rapid Micro Biosystems Q1 revenue $5.0M (+21% YoY); reaffirms FY23 guidance of at least $22.0M
--------------------------------------------------------------------------------

- Total revenue $5.0M, up 21% YoY; recurring revenue $3.3M (+22%).
- Net loss $13.9M ($0.32/share) vs $14.9M ($0.35) in Q1 2022.
- Placed three Growth Direct systems; two systems validated in the quarter.
- Reaffirmed FY2023 revenue guidance of at least $22.0M (~30% growth) and at least 15 placements.
- Appointed Michael Wysocki SVP Sales and Marketing; cash $122.1M, no debt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1380106/000138010623000072/0001380106-23-000072-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1380106/000138010623000072/rpid-20230505.htm
  HTML page:      https://secwatch.observer/filing/0001380106-23-000072

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer